The risk of vancomycin toxicity in patients with liver impairment
Abstract Background The influence of liver disease on the pharmacokinetic profile, the risk of acute kidney injury, and excessive drug exposure in patients treated with vancomycin was examined. Methods A retrospective cohort study was performed with patients discharged from a medical center between...
Main Authors: | Luigi Brunetti, Jong Hwa Song, David Suh, Heui Jae Kim, Yeon Hee Seong, Dae Song Lee, Seung-Mi Lee, Dong-Churl Suh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Annals of Clinical Microbiology and Antimicrobials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12941-020-00354-2 |
Similar Items
-
Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
by: Dae Il Kim, et al.
Published: (2010-12-01) -
A GC–MS-based untargeted metabolomics approach for comprehensive metabolic profiling of vancomycin-induced toxicity in mice
by: Changmeng Cui, et al.
Published: (2022-07-01) -
In Vitro Nephrotoxicity and Permeation of Vancomycin Hydrochloride Loaded Liposomes
by: Nicole Papp, et al.
Published: (2022-05-01) -
Effects of vancomycin linoleic acid nanoparticles on male reproductive indices of Sprague–Dawley rats
by: Edwin Coleridge Stephen Naidu, et al.
Published: (2021-01-01) -
Vancomycin-Induced Organizing Pneumonia: A Case Report and Literature Review
by: Young-Shin Lee, et al.
Published: (2021-06-01)